Hematology: Anemia
Anemia
Causes
- Microcytic Anemia (MCV < 80 fL)
- Iron Deficiency Anemia (IDA)
- Can Be from Chronic Blood Loss
- Anemia of Chronic Disease
- Thalassemia
- Iron Deficiency Anemia (IDA)
- Normocytic Anemia
- Acute Blood Loss Anemia
- Hemolytic Anemia
- Autoimmune Hemolytic Anemia
- Hereditary Spherocytosis
- Sickle Cell Anemia
- G6PD Deficiency
- *Any Cause of Microcytic or Macrocytic Anemia Can Also Present with Normocytic Anemia – Especially if Early in the Disease Course
- Macrocytic Anemia (MCV > 80 fL)
- Folate (B9) Deficiency
- B12 Deficiency
- Anaplastic Anemia
- Fanconi Anemia
- Diamond Blackfan Anemia
General Transfusion Thresholds
- Goal Hgb:
- General Population: 7.0 g/dL
- Preexisting Coronary Artery Disease: 8.0 g/dL
- Debated – Some Newer Literature Suggests 7.0 g/dL
- Outside of Massive Transfusion Blood Should Be Transfused One Unit at a Time
- Can Recheck Hgb as Early as 15 Minutes After Transfusion Completion
- High Correlation of Hgb at 15 Minutes, 1 Hour & 2 Hours
Autoimmune Hemolytic Anemia (AIHA)
Definitions
- Definition: Hemolytic Anemia Due to Autoantibodies to a Patient’s Own Red Blood Cells
- Classification:
- Warm-Reactive – IgG Autoantibodies Bind Red Cells at 37°C
- Most Common (60-90%)
- Hemolysis Primarily in the Spleen (Splenectomy Can Improve)
- Generally a More Chronic Course
- Cold Agglutinin – IgM Autoantibodies Bind Red Cells at Lower Temperatures
- Hemolysis Primarily in the Liver & Intravascular (Splenectomy/Steroids Do Not Effect)
- Generally Self-Limiting
- Warm-Reactive – IgG Autoantibodies Bind Red Cells at 37°C
- Can Be Associated with Other Autoimmune Diseases (SLE, Scleroderma, etc.)
Labs
- Anemia
- Signs of Hemolysis: High Indirect Bilirubin, Low Haptoglobin, High LDH
- Blood Smear: Spherocytes
Diagnosis
- Diagnosis: Direct Antiglobulin (Coombs) Test
- Cold AIHA: Hemolytic Anemia & Direct Antiglobulin Test Positive for Bound Complement & Negative for IgG
- Warm AIHA: Hemolytic Anemia & Direct Antiglobulin Test Positive for IgG
- May or May Not Be Positive for Bound Complement
Treatment
- Cold AIHA: Avoid the Cold
- If Fails: Rituximab
- Plasmapheresis Can Remove Antibodies in the Acute Setting
- Warm AIHA: Steroids
- If Fails: Splenectomy or Rituximab
- *Severe Anemia Requires Urgent Red Blood Cell Transfusion
Hereditary Spherocytosis (HS)
Basics
- The Most Common Cause of Hemolytic Anemia
- Caused by a Defect in the Red Blood Cell Membrane
- Variant Membrane Protein Defects: Spectrin, Ankyrin, Band 3 & Band 4.2
- Can Present at Any Time in Life
Classification
- HS Trait: Normal Hgb, Bilirubin & Reticulocyte Count
- Mild HS: Hgb 11-15 g/dL, Bilirubin 1-2 mg/dL or Reticulocyte Count 3-6%
- Moderate HS: Hgb 8-12 g/dL, Bilirubin > 2 mg/dL or Reticulocyte Count > 6%
- Most Common (60-75%)
- Severe HS: Hgb 6-8 g/dL, Bilirubin > 3 mg/dL or Reticulocyte Count > 10%
Presentation
- Anemia
- Jaundice
- Pigmented (Bilirubin) Gallstones – Rare in Children Under 10 Years Old
- Splenomegaly
- Leg Ulcers – Rare
Diagnosis
- Lab Findings (Not Diagnostic):
- Spherocytes on Blood Smear
- High MCHC
- Coombs-Negative Hemolysis
- Definitive Diagnosis:
- Osmotic Fragility Test –
- EMA (Eosin-5-Maleimide) Binding Test
- AGLT (Acidified Glycerol Lysis Test)
Treatment
- Mild-Moderate Hemolysis: Supportive Measures (Folic Acid Supplementation & Blood Transfusion PRN)
- Severe Hemolysis: Splenectomy
- Concomitant Cholecystectomy if Gallstones Present – All Patients Should Have a Preoperative US to Evaluate
- Timing: After Age 5-6 (Allow Early Immune System Development to Avoid Sepsis)
Sickle Cell Disease
Definition
- Definition: Hemoglobin-S Gene Mutation on ≥ One Beta Globin Gene
- Mutation Increases Risk of Erythrocytes to Sickle (Become Rigid & Elongated)
- Sickle Erythrocytes Cause Deoxygenation, Hemolysis & Polymerization (Clumping)
Classification
- Sickle Cell Anemia – Homozygous Mutation (HbSS/SCA-)
- Sickle Cell Trait – Heterozygous Mutation (HbAS)
- Rarely is Symptomatic
- Hemoglobin SC Disease – Both a Hgb-S & Hgb-C Genes Coinherited (HbSC)
Presentation
- Hemolytic Anemia
- Vaso-Occlusive Phenomena
- Acute Chest Syndrome
- Stroke
- Renal Infarction
- Myocardial Infarction
- Priapism
- Hand-and-Foot Syndrome – Peripheral Occlusion
- Sequestration Crisis – Pain, Hypotension & Profound Anemia
- Increased Risk of Infection
- Chronic Complications:
- Pain
- Anemia
- Pulmonary Disorders
- Renal Impairment
- Seizures
- Leg Ulcers
Triggers of Acute Events
- Dehydration
- Stress
- Cold Temperature
- High Altitude
- Alcohol
- Menstruation
Acute Chest Syndrome (ACS)
- Definition: Pulmonary Sequestration of Sickled Erythrocytes
- High Mortality: 4.3% in Adults (Lower in Peds)
- Most Common Cause of Mortality in Sickle Cell Disease
- 50% of Patients with Sickle Cell Disease Will Have an Episode of ACS
- 78% are Secondary to Vaso-Occlusive Pain Episodes
- Most Common Cause: Fat Embolism
- Effects:
- Lung Infarction
- Inflammation & Atelectasis
- Ventilation-Perfusion Mismatch
- Definition: New Radiographic Evidence of Pulmonary Infiltrate & ≥ One Of:
- Chest Pain
- Fever > 38.5° C
- Respiratory Symptoms:
- Tachypnea
- Intercostal Retractions or Accessory Muscle Use
- Cough
- Wheezing or Rales
- Relative Hypoxemia (> 2% Decrease in SpO2)
- Treatment:
- Aggressive Immediate Pain Control
- Fluid Resuscitation
- Pulmonary Hygiene:
- Incentive Spirometry
- Supplemental Oxygen
- Intensive Chest Physiotherapy
- Empiric Antibiotics
- Consider Blood Transfusion
Hemolytic Disease of the Newborn (HDN)
Pathophysiology
- Alloimmunization: Rh-Negative Mother Develops Rh Antibodies
- From Exposure to Rh Antigens
- IgG Passes Through Placenta
- Causes Hemolysis During a Subsequent Pregnancy
- *Rh-Positive & Rh-Negative Nomenclature Describes the RhD Antigen Specifically Although in Reality there are Numerous Other Rh Antigens (D, d, C, c, E, e & G)
Sources of Exposure
- Delivery
- Abortion – Mother May Not Even Be Aware
- Ectopic Pregnancy
Maternal Prevention
- Prevention: Anti-D Immune Globulin (RhoGAM)
- Indications:
- D-Negative Mother
- Negative Anti-D Antibody Screen
- One of the Following:
- 28 Weeks Gestation
- After Delivery of a D-Positive Newborn
- Antepartum Event Associated with an Increased Risk of Fetomaternal Bleeding:
- Abortion (Spontaneous or Induced)
- Blunt Abdominal Trauma
- Ectopic Pregnancy
- Invasive Prenatal Procedures
- Dose: 300 mcg
- May Consider 50 mcg if in the First-Trimester